HIV New Product Introduction Toolkit

June 11, 2018

The HIV New Product Introduction Toolkit provides Ministries of Health (MoHs) and implementing partners with the tools necessary to evaluate the adoption and introduction of new products in their local context. The toolkit includes a wide-range of information, tools, and resources spanning the entire chain of product introduction including product adoption, forecasting, procurement, facility phase-in, and supply planning and monitoring, ensuring that products reach those in need of them. 

This toolkit is not meant to be prescriptive, but rather provide a framework for ministries and implementing partners to evaluate product adoption and provide tools to plan the introduction of new products. While this framework focuses on antiretrovirals (ARVs), it can be applicable to other health commodities.

What is the purpose of this toolkit?

With the availability and inclusion in WHO treatment guidelines of new, optimal ARVs, which are more efficacious, tolerable and cheaper, as well as optimal paediatric formulations which improve upon limited treatment options for children, national HIV treatment programs are preparing for big shifts in treatment guidelines and the ARV formulary.  Accelerating access to the best available treatment options not only better serves the needs of patients, but also supports significant treatment scale-up, saves money, and achieves public health goals.  Making new products widely accessible to people who can benefit from them requires high levels of planning, coordination and targeted implementation. This toolkit leverages experience from the Clinton Health Access Initiative's (CHAI's) long-term partnerships with Ministries of Health (MoHs) on new product introduction to provide tools and resources for national programs, partners and community members to evaluate, plan and execute effective transition strategies.

The HIV New Product Introduction Guide accompanies the toolkit and provides a guide for the user through the key steps of the New Product Introduction Framework, including key activities, considerations and supporting tools and resources available on the toolkit. A comprehensive checklist  for all steps in the New Product Introduction Framework has also been developed to guide Ministries of Health and partners when introducing new ARVs in-country.

Tags:
HIV medication, antiretroviral therapy (ART), pediatric ART, treatment options, antiretroviral drugs, ARVs, public health programs, national health systems, new product introduction